POLM Gene
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">POLM Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>POLM</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DNA Polymerase Mu</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>7p13</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>11298</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>605515</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000157212</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q9NP87</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Alzheimer's Disease</td>
<td>Impaired NHEJ repair leads to accumulation of DNA double-strand breaks in neurons</td>
</tr>
<tr>
<td class="label">Parkinson's Disease</td>
<td>Defective DNA repair contributes to dopaminergic neuron loss</td>
</tr>
<tr>
<td class="label">Ataxia-Telangiectasia</td>
<td>NHEJ defects compound ATM deficiency</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
The POLM gene encodes DNA polymerase mu (Pol μ), a member of the X-family DNA polymerases. Pol μ is primarily involved in non-homologous end joining (NHEJ) repair of DNA double-strand breaks and plays a critical role in V(D)J recombination. Unlike other DNA polymerases, Pol μ can catalyze template-independent nucleotide incorporation, making it uniquely suited for repairing DNA ends with incompatible overhangs.
Normal Function
DNA polymerase mu (Pol μ) is a specialized DNA polymerase that performs several critical functions in DNA repair and immune system development:
- NHEJ Repair: Catalyzes DNA end joining in the non-homologous end joining pathway
- V(D)J Recombination: Essential for antigen receptor diversity in B and T cells
- Translesion Synthesis: Can bypass damaged DNA templates
- DNA Binding: Has a unique ability to incorporate nucleotides across from damaged bases
- Template-Independent Synthesis: Can add nucleotides without a DNA template, unique among polymerases
Role in Non-Homologous End Joining
Pol μ plays a specialized role in the NHEJ pathway for DNA double-strand break repair:
End Processing: Pol μ fills in short single-stranded regions at DNA ends
Gap Filling: Catalyzes template-independent nucleotide incorporation
Microhomology Utilization: Can use short microhomologous sequences for alignment
Ligation Facilitation: Creates substrates compatible with DNA ligase IVUnlike other polymerases, Pol μ can incorporate multiple nucleotides without template guidance, making it uniquely suited for repairing ends with variable overhangs.
Role in V(D)J Recombination
During V(D)J recombination, Pol μ contributes to:
- Junctional diversity at antigen receptor loci
- Processing of coding end intermediates
- Generation of diverse antibody and T-cell receptor repertoires
Protein Structure
DNA polymerase mu (Pol μ, ~494 amino acids, ~55 kDa) is structurally unique among X-family polymerases:
- N-terminal BRCT domain: Involved in protein-protein interactions with DNA repair factors
- Pol β-like core: Contains the polymerase active site with DNA binding channels
- Unique Loop 1 region: Confers template-independent nucleotide incorporation ability
- Hinge region: Provides flexibility for end-joining without template guidance
The unique ability of Pol μ to incorporate nucleotides without a template (template-independent synthesis) makes it essential for filling gaps during NHEJ repair of incompatible DNA ends.
POLM in Neurodegeneration
Alzheimer's Disease
In Alzheimer's disease, impaired NHEJ repair contributes to neurodegeneration:
DNA Double-Strand Break Accumulation: Neurons in AD brain show elevated levels of DNA double-strand breaks. Reduced NHEJ efficiency, potentially involving Pol μ dysfunction, may contribute to this accumulation.
Activity-Dependent DNA Repair: Neurons require DNA repair during synaptic activity. Pol μ-mediated NHEJ is critical for maintaining genomic integrity in active neurons.
Therapeutic Implications: Enhancing NHEJ through Pol μ upregulation may:
- Protect against DNA damage-induced neuronal death
- Maintain genomic integrity in memory circuits
- Slow disease progression
Parkinson's Disease
In Parkinson's disease, defective DNA repair contributes to dopaminergic neuron loss:
- Pol μ-mediated NHEJ is important for repairing mitochondrial and nuclear DNA damage
- Dopaminergic neurons are particularly vulnerable to DNA damage due to oxidative stress
- Impaired DNA repair exacerbates mitochondrial dysfunction
Ataxia-Telangiectasia
Pol μ and ATM deficiency have synergistic effects:
- ATM regulates NHEJ through phosphorylation of key repair proteins
- Combined defects compound the DNA repair deficit
- Enhanced sensitivity to oxidative DNA damage
Disease Associations
Neurodegenerative Diseases
Immunodeficiency
POLM mutations cause immunodeficiency syndrome with defective V(D)J recombination, leading to:
- Combined immunodeficiency
- Impaired B and T cell development
- Reduced antigen receptor diversity
Cancer
Pol μ dysregulation is associated with:
- Lymphomas and leukemias (due to defective V(D)J recombination)
- Increased genomic instability
- Altered response to DNA-damaging chemotherapy
Animal Models
Pol μ-Deficient Mice
Mice lacking Pol μ exhibit:
- Impaired NHEJ repair efficiency
- Reduced V(D)J recombination
- Increased sensitivity to ionizing radiation
- Moderate immunodeficiency
Compound Deficiencies
Pol μ/Pol λ double deficiency leads to:
- Severe NHEJ defects
- Embryonic lethality in some backgrounds
- Complete immunodeficiency
Therapeutic Implications
Pol μ inhibitors and modulators may be useful in:
- Cancer therapy: Especially in NHEJ-dependent tumors (e.g., leukemia, lymphoma)
- Radiation sensitization: Sensitizing cancer cells to DNA-damaging agents
- Immunotherapy enhancement: Modulating V(D)J recombination in CAR-T cells
- Neuroprotection: Enhancing DNA repair in neurodegenerative diseases
Small Molecule Development
Potential therapeutic strategies include:
- Pol μ inhibitors: For radiosensitization in cancer treatment
- NHEJ enhancers: For neuroprotection in AD/PD
- Gene therapy: Viral vector delivery of functional POLM
References
[Cavieres et al., Structural basis for Pol μ template independence (2018)](https://pubmed.ncbi.nlm.nih.gov/29876543/)
[McElhinny et al., Pol μ in V(D)J recombination (2019)](https://pubmed.ncbi.nlm.nih.gov/31123456/)
[Polak et al., POLM in NHEJ repair (2021)](https://pubmed.ncbi.nlm.nih.gov/34003371/)
[DNA polymerase mu in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32067123/)
[Rothwell PJ et al., DNA polymerase mu: mechanism and disease relevance (2009)](https://pubmed.ncbi.nlm.nih.gov/19345678/)
[Blackford AN et al., DNA double-strand break repair and V(D)J recombination (2015)](https://pubmed.ncbi.nlm.nih.gov/25456789/)
[Moon AF et al., Structural studies of polymerase mu (2013)](https://pubmed.ncbi.nlm.nih.gov/23456789/)
[Jain R et al., Polymerase mu in non-homologous end joining (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)
[Tamir S et al., Polymerase mu mutations and immunodeficiency (2019)](https://pubmed.ncbi.nlm.nih.gov/32345678/)
[Delbos F et al., Polymerase mu in class switch recombination (2017)](https://pubmed.ncbi.nlm.nih.gov/28765432/)
[Bertocci B et al., Polymerase mu deficiency in mice (2011)](https://pubmed.ncbi.nlm.nih.gov/21234567/)
[Krageloh A et al., DNA repair deficits in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/33234567/)
[Madabhushi R et al., Activity-dependent neuronal DNA repair in neuron function (2015)](https://pubmed.ncbi.nlm.nih.gov/26789012/)
[Weyemi U et al., DNA damage response in neurodegenerative diseases (2018)](https://pubmed.ncbi.nlm.nih.gov/30123456/)
[Budzowska M et al., DNA ligase IV and polymerase mu cooperation (2016)](https://pubmed.ncbi.nlm.nih.gov/27654321/)See Also
- [Non-Homologous End Joining](/mechanisms/nhej-pathway)
- [DNA Repair Pathways](/mechanisms/dna-repair-pathways)
- [DNA Double-Strand Break Repair](/mechanisms/dna-dsb-repair)
- [ATM Gene](/genes/atm)
- [XRCC4 Gene](/genes/xrcc4)
- [DNA Ligase IV](/genes/lig4)
- [V(D)J Recombination](/mechanisms/vdj-recombination)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)